IntrinsicIntrinsic
← Scroll for more →

Financial Statements — UCL

Balance Sheet

(in millions USD)
MetricQ4 2025Q4 2024Q4 2023Q4 2022Q2 2022Q4 2021
Cash & Equivalents32.8330.0623.3714.9211.997.87
Short-term Investments------11.7010.1812.60
Accounts Receivable4.447.886.495.9612.9214.92
Inventory4.381.312.183.624.946.13
Total Current Assets61.2655.5649.0241.3545.5649.09
Property, Plant & Equipment2.224.032.431.181.461.80
Intangible Assets0.510.510.650.800.891.01
Total Non-current Assets6.579.427.594.5912.8518.04
Total Assets67.8364.9856.6145.9358.4167.13
Accounts Payable7.197.455.316.839.9512.99
Short-term Debt5.556.965.302.885.223.18
Total Current Liabilities36.7742.1839.1236.4448.5246.77
Long-term Debt1.62----------
Total Non-current Liabilities2.251.181.430.200.230.26
Total Liabilities39.0243.3640.5536.6448.7647.03
Retained Earnings(215.71)(222.01)(226.57)(229.38)(223.73)(209.52)
Total Stockholder Equity28.8121.6216.059.299.6620.09
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2022
Total Revenue33.64
Cost of Revenue19.85
Gross Profit13.79
Research & Development5.10
Selling, General & Admin7.99
Total Operating Expenses27.16
Operating Income(13.36)
Interest Expense0.35
Pretax Income(14.16)
Tax Provision0.12
Net Income(14.20)
Basic EPS(0.05)
Diluted EPS(0.05)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2022
Operating Cash Flow(1.98)
Capital Expenditures0.25
Free Cash Flow*(2.22)
Investing Cash Flow(0.18)
Financing Cash Flow7.00
← Scroll for more columns →

* Derived from reported values